Middle meningeal embolization for chronic subdural Hematoma: A case series of 7 patients and review of time course of resolution

IF 1.3 Q4 CLINICAL NEUROLOGY
G.K. Wong , E.Y. Cheung , R.Y. Ng , S.C. Yu , D.Y. Chan , J.T. Zhuang
{"title":"Middle meningeal embolization for chronic subdural Hematoma: A case series of 7 patients and review of time course of resolution","authors":"G.K. Wong ,&nbsp;E.Y. Cheung ,&nbsp;R.Y. Ng ,&nbsp;S.C. Yu ,&nbsp;D.Y. Chan ,&nbsp;J.T. Zhuang","doi":"10.1016/j.hest.2022.04.004","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><p>Chronic subdural hematoma (CSDH) is common in elderly after a mild or trivial head injury. The concern for embolization is the period to wait, as compared to immediate relief of mass effect from surgery. Thus, a combination approach is advocated in our center when in doubt. We here reported our initial experience and observation with respect to time course of resolution.</p></div><div><h3>Method</h3><p>We retrospectively reviewed all the patients with CSDH undergoing Onyx middle meningeal artery (MMA) embolization with curative intent and excluded patients for palliative treatment in a neurosurgical center in Hong Kong.</p></div><div><h3>Results</h3><p>Four (50%) CSDH were treated with MMA embolization alone and 4(50%) CSDH were treated with both surgery and MMA embolization. For the 4 patients with MMA embolization alone, one(25%) achieved significant reduction at 6 weeks and 3(75%) achieved resolution at 3 months. For the 4 CSDH with both surgery and MMA embolization, all have resolution at the first follow-up imaging, two(50%) at 6 weeks and 2(50%) at 3 months. There were no procedure related complications, and there were no recurrence nor reoperation in all CSDH.</p></div><div><h3>Conclusion</h3><p>MMA embolization is safe and feasible within the framework of surgery to cure and prevent recurrence.</p></div>","PeriodicalId":33969,"journal":{"name":"Brain Hemorrhages","volume":"4 1","pages":"Pages 30-33"},"PeriodicalIF":1.3000,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Brain Hemorrhages","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2589238X22000171","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 3

Abstract

Introduction

Chronic subdural hematoma (CSDH) is common in elderly after a mild or trivial head injury. The concern for embolization is the period to wait, as compared to immediate relief of mass effect from surgery. Thus, a combination approach is advocated in our center when in doubt. We here reported our initial experience and observation with respect to time course of resolution.

Method

We retrospectively reviewed all the patients with CSDH undergoing Onyx middle meningeal artery (MMA) embolization with curative intent and excluded patients for palliative treatment in a neurosurgical center in Hong Kong.

Results

Four (50%) CSDH were treated with MMA embolization alone and 4(50%) CSDH were treated with both surgery and MMA embolization. For the 4 patients with MMA embolization alone, one(25%) achieved significant reduction at 6 weeks and 3(75%) achieved resolution at 3 months. For the 4 CSDH with both surgery and MMA embolization, all have resolution at the first follow-up imaging, two(50%) at 6 weeks and 2(50%) at 3 months. There were no procedure related complications, and there were no recurrence nor reoperation in all CSDH.

Conclusion

MMA embolization is safe and feasible within the framework of surgery to cure and prevent recurrence.

中脑膜栓塞治疗慢性硬膜下血肿:7例病例及治疗时间回顾
慢性硬膜下血肿(CSDH)常见于轻度或轻微头部损伤后的老年人。与手术后立即缓解肿块影响相比,栓塞需要等待一段时间。因此,当我们有疑问时,我们中心提倡采用组合方法。我们在这里报告了我们在解决时间进程方面的初步经验和观察。方法回顾性分析了所有在香港神经外科中心接受Onyx脑膜中动脉(MMA)栓塞治疗的CSDH患者,并排除了姑息治疗的患者。对于4名单独使用MMA栓塞的患者,1名(25%)在6周时显著减少,3名(75%)在3个月时消退。对于同时进行手术和MMA栓塞的4例CSDH,所有患者在第一次随访成像时都有分辨率,6周时有2例(50%),3个月时有2名(50%)。所有CSDH均无手术相关并发症,无复发或再次手术。结论MMA栓塞在手术治疗和预防复发的框架内是安全可行的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Brain Hemorrhages
Brain Hemorrhages Medicine-Surgery
CiteScore
2.90
自引率
0.00%
发文量
52
审稿时长
22 days
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信